Infectious Disease Diagnostic Testing Kit Market

Infectious diseases are disorders caused by organisms ? such as bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful. But under certain conditions, some organisms may cause disease

Infectious Disease Diagnostic Testing Kit Market contains market size and forecasts of Infectious Disease Diagnostic Testing Kit in global, including the following market information:

Global Infectious Disease Diagnostic Testing Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Infectious Disease Diagnostic Testing Kit Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Infectious Disease Diagnostic Testing Kit companies in 2021 (%)

The global Infectious Disease Diagnostic Testing Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bacteria Caused Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Infectious Disease Diagnostic Testing Kit include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Infectious Disease Diagnostic Testing Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Infectious Disease Diagnostic Testing Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Infectious Disease Diagnostic Testing Kit Market Segment Percentages, by Type, 2021 (%)

Bacteria Caused Disease

Fungi Caused Disease

Parasites Caused Disease

Influenza

HIV

Ebola

COVID-19

Other Virus Caused Disease

Global Infectious Disease Diagnostic Testing Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Infectious Disease Diagnostic Testing Kit Market Segment Percentages, by Application, 2021 (%)

Hospitals

Scientific Research

Global Infectious Disease Diagnostic Testing Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Infectious Disease Diagnostic Testing Kit Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Infectious Disease Diagnostic Testing Kit revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Infectious Disease Diagnostic Testing Kit revenues share in global market, 2021 (%)

Key companies Infectious Disease Diagnostic Testing Kit sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Infectious Disease Diagnostic Testing Kit sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Cellex

Abbott

Roche

BioMedomics

BD

Henry Schein

Safecare Bio-Tech

Mayo Clinic Laboratories

Chembio Diagnostics

Mount Sinai Laboratory

Ortho Clinical Diagnostics

Zhejiang Orient Gene Biotech

Innovita Biological Technology

Guangzhou Wondfo Biotech

Guangdong Hecin-Scientific

Dynamiker Biotechnology (Tianjin)

ADVAITE